This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Asia: Oligonucleotide & Peptide Therapeutics
24-26 Feb, 2026
Japan

Yamasa

Profile

We provide modified amidite monomers and oligonucleotides including process development. The new GMP plant for oligonucleotides APIs stated operation. Yamasa offers custom synthesis of oligonucleotides and modified amidite monomers used in drug development. Yamasa is expanding business in mRNA field.